Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors



Rating:

Share or cite this content

Citations should be made in the following way:
S. Louhaichi (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), N. Boubaker (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia). Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19?. 808

Member's Comments

No comment yet.

Related content which might interest you: Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing Source: Eur Respir J 2016; 47:1313-1314 Year: 2016 D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006 D-dimer testing and pre-test probability scoring in the diagnosis of venous thromboembolism Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 The changing of D-dimer in the thrombolytic process of pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Quantitative D-dimer levels in pulmonary thromboembolism and community acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007 Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 The COPD frequency in patients with venous thrombosis Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Prognostic value of D-dimer, BNP and CRP in acute pulmonary thromboembolism and relationship with echocardiography Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin. Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Venous thromboembolism in patients immobilised at home Source: Eur Respir J 2015; 45: 1728-1731 Year: 2015 Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006 Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020